Description
This clinical trial is being conducted to evaluate biomarkers of Atopic Dermatitis in pediatric patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not medically advisable.
Criteria & Qualifications:
• Males and Females in good general health.
• Patients with moderate to severe AD whose disease is not adequately controlled with topical therapies.
• Must be 0 years to 11 years old.
Compensation:
Contact us for more information
